Impact of Inhibitors and L2 Antibodies upon the Infectivity of Diverse Alpha and Beta Human Papillomavirus Types

• Kihyuck Kwak,

  Affiliation Department of Pathology, The Johns Hopkins University, Baltimore, Maryland, United States of America

  ⨯
• Rosie Jiang,

  Affiliation Department of Pathology, The Johns Hopkins University, Baltimore, Maryland, United States of America

  ⨯
• Joshua W. Wang,

  Affiliation Department of Pathology, The Johns Hopkins University, Baltimore, Maryland, United States of America

  ⨯
• Subhashini Jagu,

  Affiliation Department of Pathology, The Johns Hopkins University, Baltimore, Maryland, United States of America

  ⨯
• Reinhard Kirnbauer,

  Affiliation Laboratory of Viral Oncology, Division of Immunology, Allergy and Infectious Diseases, Department of Dermatology, Medical University Vienna (MUW), Vienna, Austria

  ⨯
• Richard B. S. Roden

  * E-mail: roden@jhmi.edu

  Affiliations Department of Pathology, The Johns Hopkins University, Baltimore, Maryland, United States of America, Department of Gynecology and Obstetrics, The Johns Hopkins University, Baltimore, Maryland, United States of America, Department of Oncology, The Johns Hopkins University, Baltimore, Maryland, United States of America

  ⨯